RT Journal Article
SR Electronic
T1 ̃Evaluating reduction in CoViD-19 cases by isolation and protective measures in São Paulo State, Brazil, and scenarios of release
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.19.20099309
DO 10.1101/2020.05.19.20099309
A1 Yang, Hyun Mo
A1 Junior, Luis Pedro Lombardi
A1 Castro, Fabio Fernandes Morato
A1 Yang, Ariana Campos
YR 2020
UL http://medrxiv.org/content/early/2020/06/04/2020.05.19.20099309.abstract
AB São Paulo State registered the first case of CoViD-19 on 26 February, the first death due to CoViD-19 on 16 March, and implemented the isolation of the population in non-essential activities on 24 March, which is programmed to end on 1 June. A mathematical model considering young (below 60 years old) and elder (above 60 years) subpopulations was formulated based on the natural history of CoViD-19 to study the transmission of the new coronavirus in São Paulo State, Brazil. This deterministic model used the data collected in São Paulo State to estimate the model parameters and to evaluate the effects of herd protection, that is, isolation and personal and collective protective measures. Based on the estimated parameters, we evaluated the scenarios of three releases divided in equal proportions elapsed by 14 days between releases, but beginning in three different times (the first release occurring on 1 and 23 June, and 6 July). We concluded that these three strategies of release are equivalent (little difference) in reducing the number of severe CoViD-19 if social behaviour does not change. However, if protective measures as using face mask and hygiene (washing hands, for instance) and social distancing could be massively disseminated in the population to decrease the transmission of CoViD-19 by 80%, we concluded that the health care system may not collapse with release.Competing Interest StatementThe authors have declared no competing interest.Funding StatementExternal funding was not receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NoneAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available in Ministry of Health (Brazil) at https://covid.saude.gov.br. https://covid.saude.gov.br.